Luis Miguel Fernández Mollá

In this video, Dr Jose Luis Garcia Galaviz, from the Noreste University in Mexico, talks to us about the importance of #technologicalinnovation when observing #clinicalsimulation scenarios and evaluating #students in a manner which is objective and fair. Check it out here: https://lnkd.in/dUm47_Vh

5

📢 #BIAlert Sepsis, the AI system developed by the Instituto de Ingeniería del Conocimiento - IIC to predict sepsis, obtains CE marking as a medical device. This certificate guarantees it as a medical device in accordance with the requirements of quality, safety, efficacy and correct information required by EU directives and the Spanish Agency for Medicines and Medical Devices (#AEMPS) for its commercialisation. In this way, #BIAlert Sepsis has gone from being a research project to becoming a validated tool in healthcare practice and has already been demonstrating its efficacy for two and a half years at the Hospital Son Llàtzer in Palma de Mallorca. Read more here: https://lnkd.in/e2buNmaH

14

Universidad Politécnica de Madrid UPM participated in the ‘Digital Oncology: supporting clinical trials with biomedical sensors and wearables in cancer treatment and post-cancer follow up’ leading this mini symposium, within the 46th annual IEE EMBS international conference (15-19 July, orlando, USA). In particular contribution on the discussion of these two slots: “Designing protocols and data analysis for discovering predictors and risk factors in chronic diseases” presenting study design and challenges addressed. Benefits and opportunities of RWD through wearables and sensors for innovative cancer treatment and survivorship methods and tools in the context of clinical trials” showcasing the technology solution developed within the clinical trial rationale. During the congress, BD4QoL promoted the project results showing the relevant oncology research-specific considerations regarding how patient health status and routinely collected data can support the delivery of health care, as well as provide critical evidence for improving their quality of life.

8

1 comentario

Mastering Quality Control in Digital Pathology! Join us for an insightful lecture with Elvira Purqueras from the Hospital Universitari de Bellvitge in Barcelona as she takes you through the vital aspects of quality control in digital pathology.  In this session, she will cover everything from tissue preparation to the challenges posed by digital artifacts. If you're interested in understanding how to manage and mitigate issues before they reach the diagnostic stage, this is a must-attend event! Here’s what you’ll learn: -Key steps in preparing tissue sections for digital pathology.  -Common artifacts and their impact on diagnostics.  -Effective strategies for preventing and mitigating tissue preparation errors.  -Automatic tools for detecting errors and ensuring quality control. Whether you are a pathology technician, a medical researcher, or just curious about how AI integrates into pathology workflows, this lecture will provide essential knowledge for mastering the digital pathology landscape. Ready to enhance your pathology skills? Join us at ESDIP Academy and take your expertise in quality control to the next level. Tune in here: https://lnkd.in/dfTmZqB8 #DigitalPathology #QualityControl #HealthcareInnovation #ESDIPAcademy #MedicalInformatics #AIInPathology

60

1 comentario

Dr Margarita Melgoza is the coordinator of the #medicalsimulation centre at the Universidad del Noreste in Mexico. In this video, she talks to us about the changing use of technology in #medsim. She concentrates on how technological solutions such as Codimg help to generate #bigdata for the analysis of #healthcare training scenarios, allowing #teachers to improve their practice and #students to become better professionals. Watch it here: https://lnkd.in/dHkNGAGu

7

Who we are: Let us introduce the dedicated experts behind JACARDI. Meet Ane Fullaondo Zabala, Co-Leader of Health literacy and awareness Work Package Instituto de Investigación en Sistemas de Salud Biosistemak, Spain 🔷What does being a WP Co-leader in JACARDI mean to you in your career? Participating as WP co-leaders in #JACARDI offers us the opportunity to be actively involved in the development and coordination of the project's core activities, which in some way guide and facilitate regions in the great challenge of implementing sustainable #HealthLiteracy interventions that can evolve paradigms of health systems. Being part of this process fosters our professional growth by training us in innovative and transformative processes. 🔷What are your motivations, challenges, and mission for this project? As a health systems research institute focused on improving #HealthCare in the Basque Country and improving regional #PublicHealth and community care strategies, our role is to catalyse the necessary changes in our context, using our expertise and experience to mobilise the relevant levers and make progress in the areas of health literacy and integrated care pathways. #EU4Health #HealthUnion

34

Studying the role of extracellular vesicles in neuroinflammation: in this review article, Andrea Cabrera-Pastor at the University of Valencia aimed to summarise the current understanding of the involvement of EVs in neuroinflammation by elucidating their mechanisms of action and exploring their therapeutic potential, providing a comprehensive overview of the role of EVs in mediating intercellular communication during neuroinflammatory processes https://lnkd.in/epYgYcvv She explored the bidirectional communication networks between the brain and other essential organs, paving the way for innovative therapeutic interventions targeting EVs in neurological disorders. #extracellularvesicles #exosomes #neuroinflammation #crosstalk #Vesiculab

42

1 comentario

FULL DIGITAL WORKFLOW with SIS PRODUCTS: INTRA/EXTRA-ORAL SCANBODY. SIMPLIFIES THE WAY OF WORKING. Scanning abutment that serves both for intraoral scans (clinic) and for use in plaster or resin models (laboratory). ... SIMPLIFICA LA FORMA DE TRABAJAR. Sirve tanto para escaneados intraorales (clínica) como para su utilización en modelos de escayola o resina (laboratorio). #DentalImplants #CompatibleComponents #Prosthetics #Abutments #Dentures #Implants #smartimplantsolutions #cadcam #dental #dentallaboratory #dentalalab #dentistry #dentalhealth #implantesdentales #implantologia #implantedental #cadcamdental #cadcamdentistry #cadcamlab #ScanBodies #HealingAbutments #Screws #MUA #Locators #Analogs #TiBase

3

📩 Re-post (2min read). 🔎A systematic review conducted by the IECS - Instituto de Efectividad Clínica y Sanitaria and the Medical Technology Research Group (MTRG) from The London School of Economics and Political Science (LSE) in a project funded by the PCC identified a comprehensive evidence-based list of criteria and sub-criteria that could be considered for the creation of a value framework for the coverage decision and reimbursement of this type of technology. 🧬After analyzing in detail the data of 42 new value frameworks, 18 criteria and 36 individual sub-criteria were identified. You can see the list in this study, published in the prestigious journal Value in Health. 📃Paper link https://bit.ly/3ylRCon Ref: PCC-054 --- The PCC is a non-profit organization dedicated to driving global access to comprehensive genomic testing for all patients with cancer. The PCC is composed of and funded by: AstraZeneca, Bayer, GSK, Johnson & Johnson, Lilly, Novartis, and Roche, at the time of writing. Benjamin M. Horbach Ivana Cattaneo Nicole St Jean Gabriele Allegri John Longshore, Ph.D., FACMG Collin Churchill Kimberly Noel M.D. M.P.H Giuliana Vitoriano Testa Montenegro Tricia Bal, MD, MBA

34

🎖Check out the Highly cited #Review "Challenges in the Early Diagnosis of Oral Cancer, Evidence Gaps and Strategies for Improvement: A Scoping Review of Systematic Reviews" 🧐by Miguel Angel Gonzalez Moles et al. Universidad de Granada Access the full paper here▶️ https://lnkd.in/dzUXqqwF Keywords: oral cancer; diagnostic delay; early diagnosis; prognosis; scoping review; systematic review; meta-analysis

1

🔬Are you familiar with the groundbreaking research uncovering the pivotal role of immune proteins in liver cirrhosis? At the forefront of research, the Department of Clinical Medicine at Miguel Hernández University of Elche (UMH) is shedding light on the immune system's involvement in advanced chronic liver disease. By conducting a series of experiments utilizing mouse cirrhosis models and human tissue samples, they've investigated the interaction between the protein LSECtin and the immune response within the liver. 💡Their findings unveil a critical insight: reducing LSECtin levels leads to an uptick in a specific type of immune cells within the liver, exacerbating the progression of the disease. This discovery suggests that replenishing these levels could hold the key to restoring compromised liver functions in cirrhosis. Our team also actively contributes to the study of liver diseases like liver cirrhosis. VOKA Anatomy Pro, our flagship product, provides a comprehensive understanding of liver anatomy and pathology for medical students and professionals. Through visualization, users grasp liver disease concepts more effectively, gaining deeper insight into the immune system's role in liver pathology. 💌​​Connect with us to explore more about VOKA Anatomy Pro and our other cutting-edge medical solutions. 🔗For more details on the research, click here: https://lnkd.in/d-GWvbJF #healthcare #medtech #digitallearning #vokaio

30

¡Di adiós a las complicaciones relacionadas con el catéter! 🇪🇸 Did you know that taurolidine-based lock solutions are recommended in 𝟮𝟬+ 𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗮𝗻𝗱 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗴𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀 today? Let’s look at 𝗦𝗽𝗮𝗶𝗻, for example:  ✔️ In 2017, the Spanish Clinical Guidelines on Vascular Access for Haemodialysis noted that ”𝘊𝘝𝘊 [𝘤𝘦𝘯𝘵𝘳𝘢𝘭-𝘷𝘦𝘯𝘰𝘶𝘴 𝘤𝘢𝘵𝘩𝘦𝘵𝘦𝘳] 𝘭𝘰𝘤𝘬 𝘸𝘪𝘵𝘩 𝘢𝘯𝘵𝘪𝘴𝘦𝘱𝘵𝘪𝘤𝘴, 𝘴𝘶𝘤𝘩 𝘢𝘴 𝘵𝘢𝘶𝘳𝘰𝘭𝘪𝘥𝘪𝘯𝘦...𝘩𝘢𝘷𝘦 𝘴𝘩𝘰𝘸𝘯 𝘦𝘧𝘧𝘪𝘤𝘢𝘤𝘺 𝘢𝘨𝘢𝘪𝘯𝘴𝘵 𝘵𝘩𝘦 𝘣𝘢𝘤𝘵𝘦𝘳𝘪𝘢𝘭 𝘣𝘪𝘰𝘧𝘪𝘭𝘮 𝘢𝘯𝘥 𝘪𝘯 𝘊𝘙𝘉 [𝘤𝘢𝘵𝘩𝘦𝘵𝘦𝘳-𝘳𝘦𝘭𝘢𝘵𝘦𝘥 𝘣𝘢𝘤𝘵𝘦𝘳𝘢𝘦𝘮𝘪𝘢] 𝘱𝘳𝘰𝘱𝘩𝘺𝘭𝘢𝘹𝘪𝘴." (1) ✔️ Five years later, the Spanish Society of Intensive and Critical Care Medicine and Coronary Care Units (SEMICyUC) followed suit and stated: “𝘊𝘶𝘳𝘳𝘦𝘯𝘵𝘭𝘺, 𝘵𝘩𝘦 𝘭𝘰𝘤𝘬𝘪𝘯𝘨 𝘰𝘧 𝘊𝘝𝘊𝘴 𝘸𝘪𝘵𝘩 𝘵𝘢𝘶𝘳𝘰𝘭𝘪𝘥𝘪𝘯𝘦 𝘪𝘴 𝘵𝘢𝘬𝘪𝘯𝘨 𝘰𝘯 𝘢𝘯 𝘪𝘮𝘱𝘰𝘳𝘵𝘢𝘯𝘵 𝘳𝘰𝘭𝘦 𝘪𝘯 𝘵𝘩𝘦 𝘱𝘳𝘦𝘷𝘦𝘯𝘵𝘪𝘰𝘯 𝘰𝘧 𝘊𝘙𝘉𝘚𝘐, 𝘦𝘴𝘱𝘦𝘤𝘪𝘢𝘭𝘭𝘺 𝘪𝘯 𝘤𝘦𝘳𝘵𝘢𝘪𝘯 𝘧𝘪𝘦𝘭𝘥𝘴 𝘴𝘶𝘤𝘩 𝘢𝘴 𝘩𝘰𝘮𝘦 𝘱𝘢𝘳𝘦𝘯𝘵𝘦𝘳𝘢𝘭 𝘯𝘶𝘵𝘳𝘪𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘰𝘵𝘩𝘦𝘳 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘢𝘵 𝘩𝘪𝘨𝘩 𝘳𝘪𝘴𝘬 𝘰𝘧 𝘤𝘢𝘵𝘩𝘦𝘵𝘦𝘳 𝘪𝘯𝘧𝘦𝘤𝘵𝘪𝘰𝘯 (𝘦.𝘨. 𝘰𝘯𝘤𝘰𝘭𝘰𝘨𝘺 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴).” (2) We are very pleased to see that more and more experts recognise the potential of taurolidine for patients in dialysis, oncology, and parenteral nutrition. Driving medical progress together all over the world! 🌍 ¿Quiere saber más sobre el uso de las soluciones TauroLock™ en España? ¡Nuestros socios Mariano Molina Ortega en Bionet Medical S.L. estarán encantados de ayudarle! #tauropharm #taurolock #taurolidine #antimicrobial #infectionprevention 1) Ibeas et al. Journal of the Spanish Society of Nephrology (Sociedad Española de Nefrología, SEN) 2017. DOI: 10.1016/j.nefro.2017.11.004  2) Spanish Society of Intensive and Critical Care Medicine and Coronary Care Units (SEMICyUC) 2022. 

32

8 comentarios

🌟 Driving Precision in Medical Device Manufacturing 🌟 At SpecialTeam and proNet, we assist in the design and development of medical devices. We understand the critical role of contract manufacturing in the medical device industry. Our primary goal? To ensure that every product meets rigorous standards and is produced at scale with consistency and precision. From SpecialTeam’s Cleanroom Assembly & Packaging Services to proNet’s Sourcing & Manufacturing Solutions, we leverage specialized techniques and quality control measures to deliver top-tier devices that adhere to exact specifications. Why partner with us? 🔹 Expertise in Specialized Manufacturing Processes: Precision and consistency are at the core of our assembly techniques, ensuring optimal performance. 🔹 Dedicated Cleanroom Facilities: Designed to maintain sterility and eliminate contaminants, critical for medical devices. 🔹 Rigorous Quality Assurance: Every step is monitored and controlled to maintain the highest standards. Explore how our manufacturing services can enhance your device’s quality and reliability: 🔗 https://lnkd.in/e5TmFn6t 🔗 https://lnkd.in/eecNK_Gd With a commitment to quality and compliance, SpecialTeam and proNet are your trusted partners in contract manufacturing for medical devices. #MedicalDeviceManufacturing #QualityControl #ContractManufacturing #CleanroomAssembly #SpecialTeam #proNet

3

🔍 Discover the cost-effectiveness of pharmacogenetic screening in treating Major Depressive Disorder (MDD). This approach could save costs and improve patient outcomes in the Spanish National Health System. Read more to understand the potential benefits and future implications. 🌐💡 #SyenzaNews #Pharmacogenetics #MajorDepression #CostEffectiveness #HealthcareInnovation https://lnkd.in/dgcPfFJc

5

2 comentarios

📢 A new paper is out! 🔊 Thanks to our collaboration with the Infectios Diseases Unit of the General Hospital of Elche-Fisabio foundation we publised together a paper in the Journal Clinical Infectious Diseases entitled "Virological History Predicts Non-sustained Viral Suppression with Long-Acting Cabotegravir and Rilpivirine Therapy, independent of Pharmacokinetic Parameters". 🔬 This study investigated the factors contributing to non-sustained viral suppression, such as intermittent viremia and persistent low-level viremia, during long-acting (LA) injectable therapy with cabotegravir (CAB) and rilpivirine (RPV), with a specific focus on pharmacokinetics (PK). The findings suggest that non-sustained viral suppression in people with HIV (PWH) transitioning from stable oral ART to CAB+RPV LA was associated with pre-existing factors prior to the transition. Elevated viral loads before ART initiation and incomplete suppression during oral therapy increased the risk, regardless of PK parameters. 🎙 Congrats to Félix Gutiérrez, Marta Fernández González, Christian Ledesma, María Losada Echeberria, Enrique Barrajón-Catalán, Javier García-Abellán, Daria De Stefano, Leandro López, Melissa Belló Pérez, Sergio Padilla and Mar Masiá 📜 More information: https://lnkd.in/dqZ_m5wi #virology #infectiousdiseases #HIV #Pharmacokinetics #longacting #treatment

16

#Review Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence by Elda A. Flores-Contreras, et al. https://lnkd.in/egzVzexY MDPI Universidad Autónoma de Nuevo León #SARSCoV2 #COVID19 #microfluidic #chip #biosensors #diagnostics #openaccess #Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the ongoing COVID-19 (coronavirus disease-2019) outbreak and has unprecedentedly impacted the public health and economic sector. The pandemic has forced researchers to focus on the accurate and early detection of SARS-CoV-2, developing novel diagnostic tests. Among these, microfluidic-based tests stand out for their multiple benefits, such as their portability, low cost, and minimal reagents used. This review discusses the different microfluidic platforms applied in detecting SARS-CoV-2 and seroprevalence, classified into three sections according to the molecules to be detected, i.e., (1) nucleic acid, (2) antigens, and (3) anti-SARS-CoV-2 antibodies. Moreover, commercially available alternatives based on microfluidic platforms are described. Timely and accurate results allow healthcare professionals to perform efficient treatments and make appropriate decisions for infection control; therefore, novel developments that integrate microfluidic technology may provide solutions in the form of massive diagnostics to control the spread of infectious diseases.

20

📢 New Guidelines for WES procedures in prenatal diagnosis by the Spanish Society of Gynecology and Obstetrics (SEGO) and Spanish Association of Prenatal Diagnosis (AEDP). 1. Trio WES 👨‍👩‍👧 is recommended as a 1️⃣ first-tier genetic test with specific structural abnormalities such:   - 💧 Bilateral hyperechogenic, dysplastic, or polycystic kidneys   - 🦴 Skeletal dysplasia   - ♻️ Recurrent anomaly   - 🧠 Craniosynostosis   - 🚼 Fetal akinesia deformation sequence   - 🔄 Multiple anomalies involving various systems   - 🧠 Central nervous system anomalies (except single anomalies)   - 🌊 Non-isolated nuchal translucency   - 💧 Non-immune hydrops fetalis 2. Previous genetic tests (such as QF-PCR and CMA) have not identified genetic alterations 🧬. 3. Strong suspicion of recurrence based on family history, such as previous fetuses or children with structural anomalies where no prior genetic studies were available 🧑‍🤝‍🧑. Each center should decide which of the four reporting levels to adopt: 1. Level 1️⃣: Primary findings 2. Level 2️⃣: Level 1 + Incidental findings (genes with high penetrance that are associated with moderate or severe childhood-onset diseases 🧒 3. Level 3️⃣: Levels 1 and 2 + Carrier Status for recessive conditions in both parents 👨‍👩‍👧‍👦. 4. Level 4️⃣: Levels 1, 2, and 3 + Secondary findings (early and late onset medically actionable ACMG gene list 🏥 Other important considerations in the guidelines covered: 1. 🛠️ Technical considerations 2. 📊 Quality assessment 3. 🩺 Clinical considerations 4. 🔄 Reanalysis 5. 💬 Pre-test and post-test genetic counselling 6. 🗄️ Data storage and data protection policies 📄 Excellent document enhancing the prenatal diagnostic landscape in Spain. https://lnkd.in/dyUjJDUp #WES #prenataldiagnostics #NGS #ultrasoundanomalies #prenatalcare #exome #SEGO Asociación Española de Diagnóstico Prenatal Fundación iMaterna #genomicmedicine

53

1 comentario